Business
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company today announced the launch of its new Sancuso® (granisetron transdermal system) website. The website is designed to provide health care professionals and patients with enhanced access to educational resources, clinical information and expert insights related to the prevention of chemotherapy-induced nausea and vomiting (CINV). The website also features the brand's key message: "Sancuso – the Difference between Lif
About this update from Cumberland Pharmaceuticals Inc.
[{"type":"text","content":"Sancuso – the Difference Between Life and Living","length":48,"tagName":"p","attribs":{}},{"type":"text","content":"NASHVILLE, Tenn., March 17, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company today announced the launch of its new Sancuso® (granisetron transdermal system) website. The website is designed to provide health care professionals and patients with enhanced access to educational resources, clinical information and expert insights related to the prevention of chemotherapy-induced nausea and vomiting (CINV). The website also features the brand's key message: "Sancuso – the Difference between Life and Living."","length":577,"tagName":"p"},{"type":"image","alt":"Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)","displaySize":"","headline":null,"caption":"Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":85,"url":"https://media.zenfs.com/en/prnewswire.com/3afebe83ec3d4bc266a4bcc9278af913"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/W65H8Am_Z_mSA2sDK0ostg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3afebe83ec3d4bc266a4bcc9278af913","width":400,"height":85}},"href":"https://mma.prnewswire.com/media/84325/Cumberland_Pharmaceuticals_logo_new1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Sancuso is the first and only prescription granisetron transdermal patch approved for the prevention of chemotherapy-induced nausea and vomiting, delivering continuous medication through the skin for up to five days. The patch provides an alternative to oral antiemetic therapy and may help support patients who experience difficulty taking or retaining oral medications during chemotherapy treatment.","length":401,"tagName":"p"},{"type":"text","content":"Key features of the new Sancuso website include:","length":48,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Comprehensive Product Information:Detailed overview of Sancuso, including clinical data, prescribing information and guidance on appropriate patient use for CINV prevention during chemotherapy.","length":194,"tagName":"p"}]},{"val":[{"type":"text","content":"Healthcare Provider ...